Article examins the attempt to develop a robust and defensible means of measuring and describing the degree of patient access in mixed NICE decisions.(Source: Pharmacoeconomics, O’Neill et al)
Health Outcomes, Market Access, and HEOR Global News Resources and Jobs.
